Literature DB >> 8323355

Decreased plasma fibronectin concentrations in preterm infants with septicaemia.

M P Dyke1, K D Forsyth.   

Abstract

Changes in plasma fibronectin concentrations were determined during bacterial septicaemia in extremely preterm infants. The study was a prospective study of fibronectin concentrations in infants of less than 30 weeks' gestation. Concentrations were determined at birth, before sepsis, and throughout the episode of sepsis. Fibronectin concentrations at birth or immediately before sepsis were not significantly different between those infants who developed septicaemia and those who did not (98 (15) v 97 (10) micrograms/ml). In the infants with septicaemia, fibronectin concentrations decreased significantly on day 1 (106 (13) v 173 (18) micrograms/ml for the controls) and remained significantly lower on day 2 (123 (26) v 201 (17) micrograms/ml). By day 5 fibronectin concentrations had increased and were no longer statistically different from controls. Fibronectin is a key modulator of the immune response, with important functions in neutrophil adhesion, bacterial opsonisation, T cell activation, and vascular integrity. Acute depletion of plasma fibronectin during sepsis in preterm neonates may further abrogate their ability to control sepsis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8323355      PMCID: PMC1029302          DOI: 10.1136/adc.68.5_spec_no.557

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  27 in total

Review 1.  The staphylococcal fibronectin receptor: evidence for its importance in invasive infections.

Authors:  R A Proctor
Journal:  Rev Infect Dis       Date:  1987 Jul-Aug

2.  Fibronectin degradation products containing the cytoadhesive tetrapeptide stimulate human neutrophil degranulation.

Authors:  Y T Wachtfogel; W Abrams; U Kucich; G Weinbaum; M Schapira; R W Colman
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

Review 3.  Fibronectin: an enhancer of phagocyte function.

Authors:  R A Proctor
Journal:  Rev Infect Dis       Date:  1987 Jul-Aug

4.  Use of intravenously administered immune globulin to prevent nosocomial sepsis in low birth weight infants: report of a pilot study.

Authors:  D W Clapp; R M Kliegman; J E Baley; N Shenker; K Kyllonen; A A Fanaroff; M Berger
Journal:  J Pediatr       Date:  1989-12       Impact factor: 4.406

5.  Fibronectin promotes proliferation of naive and memory T cells by signaling through both the VLA-4 and VLA-5 integrin molecules.

Authors:  L S Davis; N Oppenheimer-Marks; J L Bednarczyk; B W McIntyre; P E Lipsky
Journal:  J Immunol       Date:  1990-08-01       Impact factor: 5.422

6.  Human B lymphocytes define an alternative mechanism of adhesion to fibronectin. The interaction of the alpha 4 beta 1 integrin with the LHGPEILDVPST sequence of the type III connecting segment is sufficient to promote cell attachment.

Authors:  A Garcia-Pardo; E A Wayner; W G Carter; O C Ferreira
Journal:  J Immunol       Date:  1990-05-01       Impact factor: 5.422

7.  Neutrophil-mediated endothelial injury in haemolytic uraemic syndrome.

Authors:  K D Forsyth; A C Simpson; M M Fitzpatrick; T M Barratt; R J Levinsky
Journal:  Lancet       Date:  1989-08-19       Impact factor: 79.321

8.  Heterogeneity of fibronectin reactivity among streptococci as revealed by binding of fibronectin fragments.

Authors:  G S Chhatwal; H Blobel
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1987       Impact factor: 2.268

9.  Buffy coat transfusions in neutropenic neonates with presumed sepsis: a prospective, randomized trial.

Authors:  J E Baley; E K Stork; P I Warkentin; S B Shurin
Journal:  Pediatrics       Date:  1987-11       Impact factor: 7.124

10.  Activation of CD4 cells by fibronectin and anti-CD3 antibody. A synergistic effect mediated by the VLA-5 fibronectin receptor complex.

Authors:  T Matsuyama; A Yamada; J Kay; K M Yamada; S K Akiyama; S F Schlossman; C Morimoto
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Pathophysiology and treatment of septic shock in neonates.

Authors:  James L Wynn; Hector R Wong
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

Review 2.  Role of innate host defenses in susceptibility to early-onset neonatal sepsis.

Authors:  James L Wynn; Ofer Levy
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.